AwardTape · Defense awards · CMC Pharmaceuticals, Inc
CMC Pharmaceuticals, Inc: $657K in DoD and DHS awards
CMC Pharmaceuticals, Inc holds 2 DoD and DHS prime awards with $657K obligated Oct 19, 2023 to May 15, 2024. Largest category: Defense systems R&D at $657K; largest buyer: Department of the Army at $657K.
| Obligated FY2024+ | $657K |
|---|---|
| Awards | 2 |
| FY2024 | $657K |
| FY2025 | $0 |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $2.2M |
| Parent company (as reported) | CMC Pharmaceuticals, Inc |
| First and latest action | Oct 19, 2023 · May 15, 2024 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense systems R&D | $657K | 2 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Department of the Army | $657K | 2 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W911SR23C0019 definitive contract | $432K | Phase ii - base year | Army | Defense systems R&D | May 15, 2024 DoD 90d |
| W911SR22C0047 definitive contract | $225K | Phase ii - base year | Army | Defense systems R&D | Oct 19, 2023 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial